Compare Tata India Pharma & Healthcare Fund vs UTI Healthcare Fund
Tata India Pharma & Healthcare Fund
UTI Healthcare Fund
Risk
Very High
Very High
Rating
2.0
4.0
Min SIP Amount
₹100
₹500
Expense Ratio
2.37
2.21
NAV
₹33.46
₹344.41
Fund Started
04 Dec 2015
01 Aug 2005
Fund Size
₹1565.28 Cr
₹1443.57 Cr
Exit Load
Exit load of 0.25% if redeemed within 30 days.
Exit load of 1% if redeemed within 30 days.
1 Year
8.91%
16.98%
3 Year
18.32%
23.35%
5 Year
13.10%
15.23%
Equity
99.13%
97.08%
Cash
0.87%
2.90%
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 8.59% |
Divi's Laboratories Ltd. | 6.36% |
Healthcare Global Enterprises Ltd. | 5.85% |
Abbott India Ltd. | 5.63% |
Rainbow Children's Medicare Ltd. | 4.90% |
Glaxosmithkline Pharmaceuticals Ltd. | 4.66% |
Cipla Ltd. | 4.53% |
Dr. Reddy's Laboratories Ltd. | 4.25% |
Max Healthcare Institute Ltd. | 4.07% |
Apollo Hospitals Enterprise Ltd. | 3.90% |
Sun Pharmaceutical Industries Ltd. | 8.71% |
Divi's Laboratories Ltd. | 5.57% |
Ajanta Pharma Ltd. | 4.80% |
Caplin Point Laboratories Ltd. | 3.95% |
Lupin Ltd. | 3.59% |
Gland Pharma Ltd. | 3.56% |
Apollo Hospitals Enterprise Ltd. | 3.46% |
Dr. Reddy's Laboratories Ltd. | 3.10% |
Alkem Laboratories Ltd. | 3.10% |
Global Health Ltd. | 2.81% |
Name
-
-
Start Date
-
-
Description
The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector.
Launch Date
04 Dec 2015
01 Aug 2005
